These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6695659)

  • 1. Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum alpha-hydroxybutyrate dehydrogenase levels.
    van der Laarse A; Hermens WT; Hollaar L; Jol M; Willems GM; Lemmers HE; Liem AH; Souverijn JH; Oudhof JH; de Hooge J
    Am Heart J; 1984 Feb; 107(2):248-60. PubMed ID: 6695659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of cumulative release of lactate dehydrogenase isoenzyme-1 in plasma of patients with acute myocardial infarction using a commercially available test.
    Ladi RN; Hollaar L; Souverijn JH; van der Laarse A
    Clin Physiol Biochem; 1990; 8(5):250-5. PubMed ID: 2103899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of enzymatic infarct size: direct comparison of the marker enzymes creatine kinase and alpha-hydroxybutyrate dehydrogenase.
    Dissmann R; Linderer T; Schröder R
    Am Heart J; 1998 Jan; 135(1):1-9. PubMed ID: 9453514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of myocardial infarction: correlation with enzymatic, angiographic, and radionuclide findings.
    Krauss XH; van der Wall EE; van der Laarse A; Doornbos J; Matheijssen NA; de Roos A; Blokland JA; van Voorthuisen AE; Bruschke AV
    Am Heart J; 1991 Nov; 122(5):1274-83. PubMed ID: 1950989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: a randomized trial of 533 patients with acute myocardial infarction.
    van der Laarse A; Vermeer F; Hermens WT; Willems GM; de Neef K; Simoons ML; Serruys PW; Res J; Verheugt FW; Krauss XH
    Am Heart J; 1986 Oct; 112(4):672-81. PubMed ID: 3532742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Markers of necrosis and anoxia in the post-infarct heart failure: determination of infarct size (author's transl)].
    Bugiardini R; Ferrini D; Gridelli C; Muscari A; Vinelli S; Zaca' F; Puddu P
    G Ital Cardiol; 1981; 11(5):608-13. PubMed ID: 7286531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of circulatory parameters in patients with acute myocardial infarction. Significance for calculation of enzymatic infarct size.
    Willems GM; Muijtjens AM; Lambi FH; Hermens WT
    Cardiovasc Res; 1979 Oct; 13(10):578-87. PubMed ID: 519660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man.
    Kleine AH; Glatz JF; Van Nieuwenhoven FA; Van der Vusse GJ
    Mol Cell Biochem; 1992 Oct; 116(1-2):155-62. PubMed ID: 1480144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction. A randomized trial conducted by The Netherlands Interuniversity Cardiology Institute.
    Bar FW; Vermeer F; de Zwaan C; Ramentol M; Braat S; Simoons ML; Hermens WT; van der Laarse A; Verheugt FW; Krauss XH
    Am J Cardiol; 1987 Jan; 59(1):6-13. PubMed ID: 3544782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition and quantification of myocardial injury by means of plasma enzyme and isoenzyme activities after cardiac surgery.
    van der Laarse A; Davids HA; Hollaar L; van der Valk EJ; Witteveen SA; Hermens WT
    Br Heart J; 1979 Jun; 41(6):660-7. PubMed ID: 313803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of plasma volume changes on enzymatic estimation of infarct size.
    Witteveen SA; Smith SJ; Bos G; Hermens WT
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():401-7. PubMed ID: 1031993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of myocardial injury by serum tumour necrosis factor alpha measurements in acute myocardial infarction.
    Hirschl MM; Gwechenberger M; Binder T; Binder M; Graf S; Stefenelli T; Rauscha F; Laggner AN; Sochor H
    Eur Heart J; 1996 Dec; 17(12):1852-9. PubMed ID: 8960428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance rates.
    de Groot MJ; Wodzig KW; Simoons ML; Glatz JF; Hermens WT
    Cardiovasc Res; 1999 Nov; 44(2):315-24. PubMed ID: 10690308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans.
    Glatz JF; Kleine AH; van Nieuwenhoven FA; Hermens WT; van Dieijen-Visser MP; van der Vusse GJ
    Br Heart J; 1994 Feb; 71(2):135-40. PubMed ID: 8130020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac troponin T release into plasma after acute myocardial infarction: only fractional recovery compared with enzymes.
    Kragten JA; Hermens WT; van Dieijen-Visser MP
    Ann Clin Biochem; 1996 Jul; 33 ( Pt 4)():314-23. PubMed ID: 8836389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?
    Vermeer F; Simoons ML; Bär FW; Tijssen JG; van Domburg RT; Serruys PW; Verheugt FW; Res JC; de Zwaan C; van der Laarse A
    Circulation; 1986 Dec; 74(6):1379-89. PubMed ID: 3779921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial creatine kinase-MB concentration in normal and explanted human hearts and released from hearts of patients with acute myocardial infarction.
    van der Laarse A; Hollaar L; Kok SW; van den Eijnde S; Souverijn JH; Hoedemaeker PJ; Bruschke AV
    Clin Physiol Biochem; 1992; 9(1):11-7. PubMed ID: 1424434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein. Influence of renal function.
    Wodzig KW; Kragten JA; Hermens WT; Glatz JF; van Dieijen-Visser MP
    Eur J Clin Chem Clin Biochem; 1997 Mar; 35(3):191-8. PubMed ID: 9127740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of thrombolytic treatment on infarct size and left ventricular function by enzymatic, scintigraphic, and angiographic methods. The European Cooperative Study Group for Recombinant Tissue Type Plasminogen Activator.
    Mortelmans L; Vanhaecke J; Lesaffre E; Arnold A; Urbain JL; Hermens W; De Roo M; De Geest H; Verstraete M; Van de Werf F
    Am Heart J; 1990 Jun; 119(6):1231-7. PubMed ID: 2112877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of infarct size in man by means of plasma enzyme levels.
    Witteveen SA; Hemker HC; Hollaar L; Hermens WT
    Br Heart J; 1975 Aug; 37(8):795-803. PubMed ID: 1191441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.